Prediction Case File
YouTubeTracking Live

Nike (NKE) Stock Hasn't Been This Low Since 2013 - Time To Buy?

1 extracted signal · 0 resolved · 1 still active

Ryne Williams profile imageRyne WilliamsIndependent analyst profile
Source published
10 Oct 2026, 13:00 UTC
Recorded by Tahlil Plus
22 Oct 2026, 15:50 UTC
Video preview for Nike (NKE) Stock Hasn't Been This Low Since 2013 - Time To Buy?
Source overview

AI-generated source summary

The video discusses Nike's (NKE) stock performance and fundamental health. Historically, NKE has shown significant growth, but in the last year, its stock price has declined substantially, down approximately 77% over the past 5 years from its peak. This decline is attributed to strategic missteps, including an over-reliance on direct-to-consumer sales at the expense of wholesale partners and a perceived decline in product innovation, particularly in running shoes. Financials indicate a significant drop in earnings per share and free cash flow per share over the last 12 months compared to previous years. However, the company maintains a strong balance sheet with substantial cash reserves and low net debt to EBITDA and net debt to capital ratios. The interest coverage ratio remains high, indicating a solid ability to service debt. While the recent dividend yield is high at 4.77%, it is considered 'Borderline Safe' due to the increasing payout ratio, which has reached 134% for earnings and 115% for free cash flow in the last 12 months. This suggests that the company is paying out more in dividends than it is earning or generating in free cash flow. Despite these challenges, the company's strong brand, ongoing product innovation in areas like running shoes (Alphafly 3), and efforts to rebuild wholesale relationships are seen as potential catalysts for a turnaround. The forward P/E ratio is noted to be well below its historical norm, suggesting the stock might be undervalued. Investors are advised to monitor the company's ability to improve earnings and cash flow to sustain its dividend payout. The current price of $34.36 is seen as a potential entry point for a rebound, with a target price around $39.60, representing a roughly 15% increase. A failure to rebound and a drop below $25.00 would invalidate this bullish outlook.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Tracking Live
Signals
1
Extracted from this source
Open
1
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
—
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. Source processing completed

    Source analysis and structured extraction completed.

  6. Live evaluation in progress

    1 signal remains active.

Analyst snapshot

Ryne Williams

Platform-wide history, separate from this source evaluation.

Reliability
—
Tracked signals
19
Historical success
—
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail